Shares of INVO Fertility (IVF) gained attention on Monday after the company posted first quarter results that came in ahead of Wall Street expectations and above prior-year levels.
The business posted loss of $3.38 per share for the latest quarter, falling short of Wall Street expectations of loss of $1.25 per share by $-2.13.
Revenue for the quarter came in at $2.02 million, ahead of analyst expectations by $40.00 thousand compared with estimates of $1.98 million.
Year-over-year, earnings improved 98.9 percent while revenue advanced 23.2 percent during the quarter.
Steve Shum, Chief Executive Officer, stated, The first quarter reflected an important period for INVO Fertility. We believe investors can now see a much cleaner operating company: the Series C-2 Preferred Stock has been eliminated, warrant liabilities have been removed, cash has increased, and stockholders’ equity has more than doubled from year-end.”
